Journal of Medical Internet Research · 2021 · 27 citations · 39 references
MedicineNeurologyNeuroscienceCognitive NeurologyDiagnostic AssessmentNeuropsychologyCognitive AssessmentCognitive Function AssessmentCognitive ImpairmentMultiple SclerosisNeurocognitive AssessmentNeuropsychological AssessmentAdult Neurocognitive AssessmentClinical Neurological ExaminationCognitive Impairment DetectionCognitive Impairment EvaluationComputerized Cognitive AssessmentComputerized Neuropsychological TestingMultiple Sclerosis CognitionNeurological Status Assessment
BACKGROUND: Cognitive impairment (CI) is one of the most prevalent symptoms of multiple sclerosis (MS). However, it is difficult to include cognitive assessment as part of MS standard care since the comprehensive neuropsychological examinations are usually time-consuming and extensive. OBJECTIVE: To improve access to CI assessment, we evaluated the feasibility and potential assessment sensitivity of a tablet-based cognitive battery in patients with MS. METHODS: In total, 53 participants with MS (24 [45%] with CI and 29 [55%] without CI) and 24 non-MS participants were assessed with a tablet-based cognitive battery (Adaptive Cognitive Evaluation [ACE]) and standard cognitive measures, including the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT). Associations between performance in ACE and the SDMT/PASAT were explored, with group comparisons to evaluate whether ACE modules can capture group-level differences. RESULTS: Correlations between performance in ACE and the SDMT (R=-0.57, P<.001), as well as PASAT (R=-0.39, P=.01), were observed. Compared to non-MS and non-CI MS groups, the CI MS group showed a slower reaction time (CI MS vs non-MS: P<.001; CI MS vs non-CI MS: P=.004) and a higher attention cost (CI MS vs non-MS: P=.02; CI MS vs non-CI MS: P<.001). CONCLUSIONS: These results provide preliminary evidence that ACE, a tablet-based cognitive assessment battery, provides modules that could potentially serve as a digital cognitive assessment for people with MS. TRIAL REGISTRATION: ClinicalTrials.gov NCT03569618; https://clinicaltrials.gov/ct2/show/NCT03569618.
39
A feature-integration theory of attention
Anne Treisman, Garry A. Gelade · Cognitive Psychology · 1980 · 12.4K citations
Medicine, Psychology, Vision Science +12
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
Chris H. Polman, Stephen C. Reingold, Brenda Banwell et al. · Annals of Neurology · 2011 · 9.8K citations · Full text
Medicine, Neurology, Neuroscience +10
New Multiple Sclerosis Phenotypic Classification
Fred Lublin · European Neurology · 2014 · 4.3K citations
Cognitive dysfunction in multiple sclerosis.
Stephen M. Rao, Gary J. Leo, Linda Bernardin et al. · Neurology · 1991 · 2.1K citations
Medicine, Neurology, Neuroscience +17